DASH prediction score
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)
Synonyms and keywords: (add synonyms and create redirects)
Overview
[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
DASH Prediction Score
[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)
[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.
[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).
[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).
DASH Prediction Score Calculator
Shown below is the calculator for DASH prediction score (check all the boxes that apply):
Interpretation
| Score | Annualized recurrence rate | Cumulative recurrence rate | ||
|---|---|---|---|---|
| 1 year | 2 year | 5 year | ||
| - 2 | ||||
| - 1 | ||||
- Score – 2: annualized recurrence rate 1.8%
- Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
- Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.
See also
- (Relevant score 1)
- (Relevant score 2)
- (Relevant score 3)